The Department of Justice (“DOJ”) on September 18, 2019, announced a $21.36 million settlement with compounding pharmacy Patient Care America (“PCA”), two PCA executives, and private equity firm Riordan, Lewis & Haden, Inc....more
2/27/2020
/ Anti-Kickback Statute ,
Compliance ,
Corporate Governance ,
Department of Justice (DOJ) ,
Drug Compounding ,
Due Diligence ,
False Claims Act (FCA) ,
Global Market ,
Health Care Providers ,
Investment Funds ,
Pharmacies ,
Private Equity ,
Private Investment Funds ,
Risk Management ,
Settlement Agreements